AZ

Americans with Disabilities Act (ADA) May Protect Physicians Wrongfully Compelled to Have Psychiatric Evaluation, according to Journal of American Physicians and Surgeons

Retrieved on: 
Thursday, March 21, 2024
Employment, Journal, Disability discrimination act, Lawyer, AAPS, Physician, Polysilazane, Nursing

in the spring issue of the Journal of American Physicians and Surgeons.

Key Points: 
  • in the spring issue of the Journal of American Physicians and Surgeons.
  • The authors assert that physician evaluees must be empowered to choose qualified evaluators who will perform examinations in a manner consistent with their legal and ethical duties.
  • Given the lack of institutional protections for physicians, the authors recommend early consultation with ADA-knowledgeable counsel.
  • The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS) , a national organization representing physicians in all specialties since 1943.

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Retrieved on: 
Thursday, March 21, 2024
Research, U.S. FDA, Conference, Growth, Journey, Agreement, FY, IGA, Microbiota, Risk, New Drug Application, Patient, Food and Drug Administration, Rosacea, Hyperhidrosis, NDA, Red, News, Adjustment, Dermatology, Clinical trial, Erythema, Doxycycline, Safety, GAAP, Food, Marketing, FDA, CEA, Total, PDUFA, Pharmaceutical industry

SCOTTSDALE, Ariz., March 21, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced financial results and recent corporate highlights for the full year ended December 31, 2023.

Key Points: 
  • ET to discuss the financial results and provide a business update
    SCOTTSDALE, Ariz., March 21, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced financial results and recent corporate highlights for the full year ended December 31, 2023.
  • Claude Maraoui, Journey Medical’s Co-Founder, President and Chief Executive Officer, said, “2023 was a year of growth and development for Journey Medical.
  • In December 2023, Journey Medical entered into a $20.0 million credit facility with SWK Holdings Corporation (“SWK”), a specialized finance company with a focus on the global healthcare sector.
  • In July 2023, Journey Medical announced positive topline results from the two DFD-29 Phase 3 clinical trials (MVOR-1 & MVOR-2) for the treatment of rosacea.

Abusive Referrals for Psychiatric Assessment Are a Tool of Sham Physician Peer Review, according to Journal of American Physicians and Surgeons

Retrieved on: 
Thursday, March 21, 2024
Mere, Psychiatry, Intellectual, Abuse, Journal, Hospital, Rehabilitation, Rehabilitation Act of 1973, Disability discrimination act, AAPS, Physician, Person, Nursing

One technique for physicians who fail to conform to official government narratives is mandatory referral for psychiatric or neuropsychological testing, writes neurologist Lawrence Huntoon, M.D ., in the spring issue of the Journal of American Physicians and Surgeons.

Key Points: 
  • One technique for physicians who fail to conform to official government narratives is mandatory referral for psychiatric or neuropsychological testing, writes neurologist Lawrence Huntoon, M.D ., in the spring issue of the Journal of American Physicians and Surgeons.
  • “Hearsay, rumor, and suspicion are often all that is needed to force physicians to undergo psychiatric and neuropsychological testing,” he writes.
  • A 2019 Resolution passed by the Association of American Physicians and Surgeons (AAPS) condemns the abuse and misuse of psychiatry in physician evaluation as unethical.
  • It states that abuse occurs when referrals are made to support illegitimate purposes or when evaluees are denied full due process.

Infectious Disease Specialist Calls Campaign against Repurposed Drugs in COVID-19 a ‘Great Hypocrisy’

Retrieved on: 
Thursday, March 21, 2024
Vanderbilt University, COVID, HCQ, Rheumatoid arthritis, Infection, Azithromycin, Lupus, Diabetes, COVID-19, Patient, Knowledge, Journal, Mortality, Addiction, Hydroxychloroquine, AAPS, Dysautonomia, Physician, Ivermectin, IVM, Pharmaceutical industry

Just before the death-knell announcement, Dr. Hoffman notes, substantial evidence favoring early use of HCQ had been submitted for publication by Dr. Harvey Risch of Yale.

Key Points: 
  • Just before the death-knell announcement, Dr. Hoffman notes, substantial evidence favoring early use of HCQ had been submitted for publication by Dr. Harvey Risch of Yale.
  • “In fact, all evidence is inherently flawed.”
    Dr. Hoffman points out how inconsistencies and double standards reveal the FDA’s hypocrisy regarding HCQ and ivermectin (IVM).
  • Paxlovid, he writes, has not been shown to be effective in hospitalized COVID patients, whereas the “flawed” study of HCQ demonstrated a greater than 60 percent benefit in reducing mortality.
  • “There is in fact a corpus of knowledge about the use of HCQ, IVM, and other off-label drugs, for example, at c19hcq.org, c19IVM.org18, and earlycovidcare.org,” Dr. Hoffman states.

Castellum, Inc. Announces 2023 Financial Results

Retrieved on: 
Thursday, March 21, 2024
GAAP, Federation, Form 10-K, CTM, Security (finance), Cryptocurrency

BETHESDA, Md., March 21, 2024 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces its results for the year ended December 31, 2023.

Key Points: 
  • BETHESDA, Md., March 21, 2024 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces its results for the year ended December 31, 2023.
  • It is expected that audited financial results for 2023 will be disclosed in its Form 10-K which the Company expects to file with the Securities and Exchange Commission at www.sec.gov after the market closes today.
  • Management uses a Non-GAAP financial measure, Recurring Cash Operating Profit (“RCOP”), as an important measure of the Company’s operating performance.
  • See below for a full reconciliation of GAAP operating loss with non-GAAP recurring cash operating profit for Q4 2023.

Microchip Technology Releases Qi® v2.0 Standards-Compliant dsPIC33-Based Reference Design

Retrieved on: 
Thursday, March 21, 2024
Foreign object, DSC, Certification, EPP, Microchip Technology, Wireless Power Consortium, Software, MPLA, Digital signal controller, Safety, WPC, MPP, Integrated circuit, Mobile phone

Powered by a single dsPIC33 Digital Signal Controller (DSC), the Qi2 reference design offers efficient control for optimized performance.

Key Points: 
  • Powered by a single dsPIC33 Digital Signal Controller (DSC), the Qi2 reference design offers efficient control for optimized performance.
  • Utilizing the Qi2 reference design helps minimize customer risk in certifying their final product, which is required to pass through the Qi certification process.
  • “The automotive-grade design and full range of hardware and software support help our customers optimize their end solutions and decrease time to market.”
    As part of the reference design, Microchip can deliver design files and software designed to create an easy design experience and first-pass success.
  • For more information or to request a demonstration or design files contact a Microchip sales representative, authorized worldwide distributor or visit Microchip’s Purchasing and Client Services website, www.microchipdirect.com .

COVID Origin Is a Gordian Knot, according to the Journal of American Physicians and Surgeons

Retrieved on: 
Wednesday, March 20, 2024
Editorial, COVID, Journal, Social media, COVID-19, AAPS, Physician, Violence, Pharmaceutical industry

To those who suffered severe economic losses, it is a personal and emotional issue.

Key Points: 
  • To those who suffered severe economic losses, it is a personal and emotional issue.
  • Also, in January 2024 the origin theories were discussed during hearings before the House Select Subcommittee on the Coronavirus Pandemic, the article notes.
  • Dr. Orient concludes that outside one’s partisan information bubble, the debate on the origin of COVID appears to be a stalemate, with complexities forming an informational Gordian knot, which is blocking urgently needed action on solvable problems.
  • The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS) , a national organization representing physicians in all specialties since 1943.

Arizona State University and Deca Technologies to Pioneer North America’s First R&D Center for Advanced Fan-Out Wafer-Level Packaging

Retrieved on: 
Tuesday, March 19, 2024
CHIPS, Intel, Arizona State University, FOWLP, Development, Amkor Technology, Research, Electronics, Artificial intelligence, ASU, SWAP, Science, Faculty, Student, Heart, Deca, Machine learning, Government, TSMC, Telescopic sight

TEMPE, Ariz., March 19, 2024 (GLOBE NEWSWIRE) -- Arizona State University (ASU) and Deca Technologies (Deca), a premier provider of advanced wafer- and panel-level packaging technology, today announced a groundbreaking collaboration to create North America’s first fan-out wafer-level packaging (FOWLP) research and development center.

Key Points: 
  • TEMPE, Ariz., March 19, 2024 (GLOBE NEWSWIRE) -- Arizona State University (ASU) and Deca Technologies (Deca), a premier provider of advanced wafer- and panel-level packaging technology, today announced a groundbreaking collaboration to create North America’s first fan-out wafer-level packaging (FOWLP) research and development center.
  • The center will combine state-of-the-art advanced-packaging technology, equipment, processes, materials, expertise and training, fostering the development of new capabilities from proof of concept to pilot scale.
  • In collaboration with Deca, ASU is committed to establishing onshore access to these advanced-packaging capabilities.
  • The Gen 2 M-Series including Adaptive Patterning technology brings unprecedented scaling to higher densities for heterogeneous integration and chiplet applications.

Freestar Supercharges Tech Agenda With Appointment of Chief Technology Officer and Additional Strategic Senior Hires

Retrieved on: 
Tuesday, March 19, 2024
NeXT, Automation, Digital marketing, Data science, Digital, SVP, Adweek, Acquisition, AI, Marketing, Burns, Machine learning, Privacy, Artificial intelligence, Advertising, Penske Media Corporation, MIQ, Video game

PHOENIX, March 19, 2024 (GLOBE NEWSWIRE) -- Freestar , the leading monetization partner for content publishers and e-commerce sites, today announced that Oliver Burns has been appointed Chief Technology Officer.

Key Points: 
  • PHOENIX, March 19, 2024 (GLOBE NEWSWIRE) -- Freestar , the leading monetization partner for content publishers and e-commerce sites, today announced that Oliver Burns has been appointed Chief Technology Officer.
  • Burns’ promotion to the role underscores Freestar’s commitment to product innovation and building the next generation of advertising technology leveraging machine learning and Artificial Intelligence in new ways.
  • Reporting to Chief Executive Officer, Kurt Donnell, Burns will oversee Freestar’s extensive ad product portfolio, maintain excellence in engineering and drive the data science and AI agenda.
  • This tripartite role provides a platform for Burns to build more award-winning solutions for Freestar’s premium publishers.

Rudy R. Miller Proffers a New Scholarship Program at Embry-Riddle Aeronautical University, the College of Business, Security and Intelligence, Prescott, Arizona Campus

Retrieved on: 
Tuesday, March 19, 2024
Embry–Riddle Aeronautical University, White collar, Minor, Security Industry Association, Miller Group, DHS, CBSI, National Security Agency, Research, International order, Rainbow, White-collar crime, Homeland security, Intelligence studies, CPP, CAE, NSA, Psychology, Aeronautics, CPE, Security, Parent, Achievement Medal, GPA, Management

SCOTTSDALE, Ariz., March 19, 2024 (GLOBE NEWSWIRE) -- Rudy R. Miller has awarded his first College of Business, Security and Intelligence (CBSI) scholarship to Embry-Riddle Aeronautical University, Prescott, AZ, student, Haley Childress. Ms. Childress is a senior pursuing her bachelor’s degree in Global Security and Intelligence Studies, with minors in Arabic and Middle Eastern Studies plus Psychology.

Key Points: 
  • Embry-Riddle Prescott’s College of Business, Security and Intelligence represents the first comprehensive degree-granting college of its kind in the United States.
  • CBSI focuses on the training of future business, security, and intelligence professionals, on both the national and international level.
  • The College’s courses of study emphasize research in the fields of global business, international security, and global intelligence.
  • Embry-Riddle Aeronautical University’s Prescott Campus is a National Security Agency (NSA) and Department of Homeland Security (DHS) designated National Center of Academic Excellence in Cyber Defense Education (CAE CDE) institution.